BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36808931)

  • 1. d-Mannose for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen: A Randomized Controlled Trial.
    Lenger SM; Chu CM; Ghetti C; Durkin MJ; Jennings Z; Wan F; Sutcliffe S; Lowder JL
    Urogynecology (Phila); 2023 Mar; 29(3):367-377. PubMed ID: 36808931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and Research Insights From a Randomized Controlled Trial for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen Therapy.
    Lenger SM; Chu CM; Ghetti C; Durkin MJ; Jennings Z; Sutcliffe S; Lowder JL
    Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e163-e170. PubMed ID: 35421017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal Estrogen Therapy Is Associated With Decreased Inflammatory Response in Postmenopausal Women With Recurrent Urinary Tract Infections.
    Meister MR; Wang C; Lowder JL; Mysorekar IU
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e39-e44. PubMed ID: 31725016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women.
    Fox KA; Lokken EM; Reed SD; Rahn DD
    Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial.
    Franssen M; Cook J; Robinson J; Williams N; Glogowska M; Yang Y; Allen J; Butler CC; Thomas N; Hay A; Moore M; Hayward G
    BMJ Open; 2021 Jan; 11(1):e037128. PubMed ID: 33441350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives.
    De Nunzio C; Bartoletti R; Tubaro A; Simonato A; Ficarra V
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33915821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis.
    Lenger SM; Bradley MS; Thomas DA; Bertolet MH; Lowder JL; Sutcliffe S
    Am J Obstet Gynecol; 2020 Aug; 223(2):265.e1-265.e13. PubMed ID: 32497610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.
    Chen YY; Su TH; Lau HH
    Int Urogynecol J; 2021 Jan; 32(1):17-25. PubMed ID: 32564121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent Urinary Tract Infection Incidence Rates Decrease in Women With Cystitis Cystica After Treatment With d-Mannose: A Cohort Study.
    Chiu K; Zhang F; Sutcliffe S; Mysorekar IU; Lowder JL
    Female Pelvic Med Reconstr Surg; 2022 Mar; 28(3):e62-e65. PubMed ID: 35272335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
    Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial.
    Hayward G; Mort S; Hay AD; Moore M; Thomas NPB; Cook J; Robinson J; Williams N; Maeder N; Edeson R; Franssen M; Grabey J; Glogowska M; Yang Y; Allen J; Butler CC
    JAMA Intern Med; 2024 Jun; 184(6):619-628. PubMed ID: 38587819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial.
    Ferrante KL; Wasenda EJ; Jung CE; Adams-Piper ER; Lukacz ES
    Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):112-117. PubMed ID: 31232721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections.
    Salvatore S; Ruffolo AF; Stabile G; Casiraghi A; Zito G; De Seta F
    Eur Urol Focus; 2023 Jul; 9(4):654-659. PubMed ID: 36621376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.
    Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N
    Trials; 2016 Jul; 17():358. PubMed ID: 27460108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections.
    Anglim B; Phillips C; Shynlova O; Alarab M
    Int Urogynecol J; 2022 Aug; 33(8):2107-2117. PubMed ID: 34003309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based review of nonantibiotic urinary tract infection prevention strategies for women: a patient-centered approach.
    Stair SL; Palmer CJ; Lee UJ
    Curr Opin Urol; 2023 May; 33(3):187-192. PubMed ID: 36862100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an orally administered combination of
    Murina F; Vicariotto F; Lubrano C
    Urologia; 2021 Feb; 88(1):64-68. PubMed ID: 32954992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent urinary tract infection management and prevention techniques among a population-based cohort of women.
    Gleicher S; Sebesta EM; Kaufman MR; Dmochowski RR; Reynolds WS
    Neurourol Urodyn; 2023 Nov; 42(8):1676-1685. PubMed ID: 37670465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Methenamine Hippurate Treatment on Urothelial Integrity and Bladder Inflammation in Aged Female Mice and Women With Urinary Tract Infections.
    Sawhill JL; Mora A; McDaniel K; Ligon MM; Lowder JL; Mysorekar IU; Chu CM
    Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e205-e210. PubMed ID: 35536668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.